...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Embargo
2
Mar 30, 2017 03:34PM
2
Mar 30, 2017 04:15PM

Just found it in bold type on the meeting home page.

"The full text of the clinical trial and late-breaking abstracts will not be posted untilĀ 4:30 p.m. ET on Friday, March 31."

1
Mar 31, 2017 11:27AM
2
Mar 31, 2017 11:36AM
3
Mar 31, 2017 12:13PM
Share
New Message
Please login to post a reply